We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure.
- Authors
Tordato, F.; Cozzi Lepri, A.; Cicconi, P.; De Luca, A.; Antinori, A.; Colangeli, V.; Castagna, A.; Nasta, P.; Ladisa, N.; Giacometti, A.; D'Arminio Monforte, A.; Gori, A.
- Abstract
Background, The prevalence and factors associated with an increased risk of renal dysfunction in HIV-infected patients receiving or not receiving antiretroviral therapy (ART) have been poorly evaluated in observational settings. Methods, Patients in the ICONA Foundation cohort with at least two creatinine values available while still ART-naïve were enrolled in the study. A logistic regression analysis was performed to identify predictors of an estimated glomerular filtration rate (eGFR) < 90 mL/min/1.73m2 at baseline. The incidence and predictors of a420% reduction in eGFR from pre-combination ART (cART) levels (or a decrease from < 90 to o90 mL/min/1.73m2) were evaluated by Poisson regression. Results, A total of 1505 patients were included in the study; 363 (24%) had eGFRo90 mL/min/1.73m2 at baseline. Older patients [odds ratio (OR) 1.58 per 10 years older; Po0.00001], female patients (OR 2.41 vs. male patients; Po0.00001), those who had diabetes and/or hypertension (OR 2.36 vs. neither; Po0.03) and patients with higher baseline CD4 count (OR 1.06 per 100 cells/μL higher; Po0.03) showed a greater risk of eGFRo90 mL/min/1.73m2. Ninety-six patients experienced an eGFR decrease of 420% from pre-cART levels (6.8 per 100 person- years). Older age [relative risk (RR) 1.41 per 10 years older; P50.005], female gender (RR 2.25 vs. male; P50.003) and current exposure to didanosine (ddI), tenofovir and protease inhibitors were the major determinants. Conclusions, We observed a relatively high rate of mild renal dysfunction in the absence of ART. In addition to traditional risk factors such as older age and diabetes/hypertension, female gender and current use of ddI, tenofovir and protease inhibitors were associated with a greater risk of decreased renal function as measured by eGFR.
- Subjects
ITALY; KIDNEY disease diagnosis; THERAPEUTIC use of protease inhibitors; ANTIVIRAL agents; HIV infection complications; TENOFOVIR; DIDANOSINE (Drug); AGE distribution; BLOOD cell count; COMPUTER software; CONFIDENCE intervals; CREATININE; DIABETES; EPIDEMIOLOGY; GLOMERULAR filtration rate; HIV infections; HYPERTENSION; KIDNEY diseases; LONGITUDINAL method; MEDICAL cooperation; SCIENTIFIC observation; HEALTH outcome assessment; POISSON distribution; RESEARCH; SEX distribution; STATISTICS; T cells; DATA analysis; MULTIPLE regression analysis; RELATIVE medical risk; TREATMENT effectiveness; THERAPEUTICS
- Publication
HIV Medicine, 2011, Vol 12, Issue 1, p4
- ISSN
1464-2662
- Publication type
Article
- DOI
10.1111/j.1468-1293.2010.00855.x